Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) have lost more than 28 percent year-to-date, even after surging more than 10.6 percent in the last month. Over the past five trading days, shares tumbled almost 5 percent, unlocking some room for upside. Or so the Vetr crowd seem to believe, as evidenced by its average price target of $94.50, which implies a potential return of 4.6 percent from current valuations.
Related Link: Here's How Crowdsourced Ratings Can Beat The Market
Seeking to better reflect this upside potential, the Vetr community decided upgrade its rating on shares of Vertex on Tuesday, from 3.0 Stars (Hold) to 3.5 Stars (Buy) - out of a possible 5.0 Stars rating.
Finally, it should be noted that, while price targets and the corresponding rating are conservative, the crowd is optimistic on the stock as 72 percent of its ratings are bullish.
Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!